獨立非執董承認疏忽致違反披露規定 富智康(02038.HK)審慎評估調查結果
富智康集團(02038.HK)公布,獨立非執行董事劉紹基於5月12日被證監會發起市場失當行為審裁處研訊程序,並處以罰款和罰則。基於有關進展,公司將審慎評估市場失當行為審裁處一旦取得市場失當行為審裁處研訊程序報告所得出調查結果,並釐定認為其繼續擔任獨立非執行董事兼公司審核委員會、薪酬委員會及提名委員會主席是否合適及妥當。公司將於有需要時在適當時候另行刊發公告。
事緣劉紹基及其他5名人士,在2019年11月至2021年4月擔任中國醫療網絡(00383.HK)董事期間,指稱延遲披露內幕消息一事。
證監會指,市場失當行為審裁處就於2014年未有在合理可行情況下盡快披露內幕消息對中國醫療網絡及其六名前董事及現任董事罰款合共420萬元;相關董事承認其疏忽行為導致中國醫療網絡違反公司披露制度的規定;市場失當行為審裁處已命令相關董事:支付證監會的調查及法律費用以及市場失當行為審裁處研訊程序訟費;及出席獲證監會認可有關公司披露制度、董事職責及企業管治的培訓課程。(ic/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.